ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 88 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is 1.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $501,000 | +615.7% | 7,900 | +217.7% | 0.00% | – |
| Q3 2019 | $70,000 | +25.0% | 2,487 | +19.2% | 0.00% | – |
| Q2 2019 | $56,000 | +55.6% | 2,087 | +8.0% | 0.00% | – |
| Q1 2019 | $36,000 | +63.6% | 1,932 | +5.3% | 0.00% | – |
| Q4 2018 | $22,000 | +175.0% | 1,835 | +358.8% | 0.00% | – |
| Q3 2018 | $8,000 | +300.0% | 400 | +33.3% | 0.00% | – |
| Q2 2018 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | +100.0% | 300 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | – | 300 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 300 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 300 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 300 | -33.3% | 0.00% | – |
| Q3 2016 | $3,000 | +200.0% | 450 | +80.0% | 0.00% | – |
| Q2 2016 | $1,000 | – | 250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ELEMENT CAPITAL MANAGEMENT LLC | 142,649 | $618,000 | 0.25% |
| ING GROEP NV | 808,229 | $3,500,000 | 0.07% |
| A.R.T. Advisors, LLC | 232,470 | $1,006,000 | 0.05% |
| OppenheimerFunds, Inc. | 3,000,000 | $12,990,000 | 0.02% |
| Edge Wealth Management LLC | 10,000 | $43,000 | 0.01% |
| First Allied Advisory Services, Inc. | 61,000 | $264,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 200,000 | $866,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 1,272,138 | $5,508,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 971,768 | $4,208,000 | 0.01% |
| Virtu Financial LLC | 18,008 | $78,000 | 0.00% |